Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Karen Schreiber; Savino Sciascia; Ian N Bruce; Ian Giles; Maria J Cuadrado; Hannah Cohen; Caroline Gordon; David Isenberg; Søren Jacobsen; Saskia Middeldorp; Marta Mosca; Sue Pavord; Massimo Radin; Dario Roccatello; Jane Salmon; Evélyne Vinet; Anne Voss; Linda Watkins; Beverley J Hunt

doi:10.1016/S2665-9913(20)30382-9

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Karen Schreiber, Savino Sciascia, Ian N Bruce, Ian Giles, Maria J Cuadrado, Hannah Cohen, Caroline Gordon, David Isenberg, Søren Jacobsen, Saskia Middeldorp, Marta Mosca, Sue Pavord, Massimo Radin, Dario Roccatello, Jane Salmon, Evélyne Vinet, Anne Voss, Linda Watkins, Beverley J Hunt

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

4 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The Lancet Rheumatology
Vol/bind	2
Udgave nummer	12
Sider (fra-til)	e735-e736
ISSN	2665-9913
DOI	https://doi.org/10.1016/S2665-9913(20)30382-9
Status	Udgivet - dec. 2020

Adgang til dokumentet

10.1016/S2665-9913(20)30382-9

Citationsformater

Schreiber, K., Sciascia, S., Bruce, I. N., Giles, I., Cuadrado, M. J., Cohen, H., Gordon, C., Isenberg, D., Jacobsen, S., Middeldorp, S., Mosca, M., Pavord, S., Radin, M., Roccatello, D., Salmon, J., Vinet, E., Voss, A., Watkins, L., & Hunt, B. J. (2020). Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians. The Lancet Rheumatology, 2(12), e735-e736. https://doi.org/10.1016/S2665-9913(20)30382-9

Schreiber, K, Sciascia, S, Bruce, IN, Giles, I, Cuadrado, MJ, Cohen, H, Gordon, C, Isenberg, D, Jacobsen, S, Middeldorp, S, Mosca, M, Pavord, S, Radin, M, Roccatello, D, Salmon, J, Vinet, E, Voss, A, Watkins, L & Hunt, BJ 2020, 'Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians', The Lancet Rheumatology, bind 2, nr. 12, s. e735-e736. https://doi.org/10.1016/S2665-9913(20)30382-9

@article{3e5ec2e3937249efb8b4491eb17c81b6,

title = "Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians",

author = "Karen Schreiber and Savino Sciascia and Bruce, {Ian N} and Ian Giles and Cuadrado, {Maria J} and Hannah Cohen and Caroline Gordon and David Isenberg and S{\o}ren Jacobsen and Saskia Middeldorp and Marta Mosca and Sue Pavord and Massimo Radin and Dario Roccatello and Jane Salmon and Ev{\'e}lyne Vinet and Anne Voss and Linda Watkins and Hunt, {Beverley J}",

year = "2020",

month = dec,

doi = "10.1016/S2665-9913(20)30382-9",

language = "English",

volume = "2",

pages = "e735--e736",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier Limited",

number = "12",

}

TY - JOUR

T1 - Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic

T2 - a letter to clinicians

AU - Schreiber, Karen

AU - Sciascia, Savino

AU - Bruce, Ian N

AU - Giles, Ian

AU - Cuadrado, Maria J

AU - Cohen, Hannah

AU - Gordon, Caroline

AU - Isenberg, David

AU - Jacobsen, Søren

AU - Middeldorp, Saskia

AU - Mosca, Marta

AU - Pavord, Sue

AU - Radin, Massimo

AU - Roccatello, Dario

AU - Salmon, Jane

AU - Vinet, Evélyne

AU - Voss, Anne

AU - Watkins, Linda

AU - Hunt, Beverley J

PY - 2020/12

Y1 - 2020/12

U2 - 10.1016/S2665-9913(20)30382-9

DO - 10.1016/S2665-9913(20)30382-9

M3 - Letter

C2 - 33163976

SN - 2665-9913

VL - 2

SP - e735-e736

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 12

ER -